"Science and Technology Innovation Board Daily" on April 3, the main contents of today's Science and Technology Innovation Board Evening News include: Zhang Ji, the controlling shareholder of Gaoce Co., Ltd., intends to inquire about the transfer of 4.99% of the shares; Sany Renewable Energy intends to invest a total of no more than US$1 billion to build two wind farm projects in Uzbekistan; Debang Technology plans to repurchase the company's shares for 40 million yuan to 80 million yuan; Han Yonggui, deputy general manager of Huitai Medical, plans to reduce his holdings of no more than 0.0309% of the company's shares.

[Hot Spotlight].

Ministry of Commerce: China and the EU agreed to restart negotiations on price commitments in the EV countervailing case as soon as possible

The Ministry of Commerce held a regular press conference on April 3. He Yadong, spokesman of the Ministry of Commerce, said that China and the EU agreed to restart negotiations on the price commitment of the anti-subsidy case for electric vehicles as soon as possible, so as to create a good environment for promoting investment and industrial cooperation between Chinese and European enterprises.

The Ministry of Commerce responds to Japan's semiconductor export control: it will take necessary measures to resolutely protect its legitimate rights and interests

The spokesperson of the Ministry of Commerce answered reporters' questions on Japan's implementation of semiconductor export control measures. A reporter asked: On April 3, 2025, the Japanese government announced the implementation of export controls on more than 10 types of semiconductor-related items.

A: China has taken note of the relevant situation. The semiconductor industry is a highly globalized field, and for some time, some countries have generalized the concept of national security, abused export control measures, and imposed sanctions and suppression on China's semiconductor and other industries, which seriously threatens the stability of the global semiconductor industry chain and supply chain, and China firmly opposes this.

China and Japan have strong complementarity in the field of semiconductors, and have formed a good situation of close integration. Japan's relevant export control measures will seriously interfere with normal business exchanges between enterprises and harm the interests of enterprises of the two countries. We hope that the Japanese side will proceed from upholding international economic and trade rules and the overall situation of China-Japan economic and trade cooperation, maintain rational decision-making, correct wrong practices in a timely manner, earnestly safeguard the legitimate rights and interests of enterprises in all countries, including Chinese and Japanese enterprises, and maintain the stability of the global semiconductor industry chain and supply chain. China will take necessary measures to resolutely safeguard its legitimate rights and interests.

Wu Qing: As an excellent representative of the private economy and new quality productivity, private science and technology enterprises hope that everyone will strengthen their confidence and maintain the spirit of love and hard work to win

Wu Qing, Secretary of the Party Committee and Chairman of the China Securities Regulatory Commission, held a symposium in Beijing to have in-depth exchanges with representatives of private science and technology enterprises in different fields such as integrated circuits, new energy vehicles, intelligent manufacturing, new materials, commercial aerospace, and network economy, and fully listened to opinions and suggestions. Wu Qing emphasized that we should respect the laws of the market, effectively improve the inclusiveness and adaptability of the capital market, continue to enhance the transparency and predictability of the rules, further improve the multi-level market service system of the whole chain and the whole life cycle, and strengthen the support of high-quality private enterprises to become stronger, better and bigger. As an excellent representative of the private economy and new quality productivity, private science and technology enterprises hope that everyone will strengthen their confidence, maintain the spirit of hard work to win, play a good role in demonstration with practical actions, actively use the capital market to transform and upgrade, be better and stronger, better return investors, and actively contribute to promoting high-quality economic development and Chinese-style modernization.

Ministry of Industry and Information Technology: Focus on the fields of integrated circuits, basic electronics and complete machine systems to cultivate and expand a number of emerging industries and future industries

On April 3, the Ministry of Industry and Information Technology held the 2025 National Electronic Information Manufacturing Industry High-quality Development Industry Conference in Taiyuan City, Shanxi Province. The meeting emphasized that it is necessary to coordinate high-quality development and high-level security, adhere to the principle of seeking progress while maintaining stability and promoting stability through progress, strive to promote the steady growth of the electronic information manufacturing industry, accelerate the digital transformation process of the electronic information manufacturing industry, and promote the high-quality development of the industry. It is necessary to strengthen scientific research and judgment, accurately grasp the new situation and new requirements faced by the development of the electronic information manufacturing industry, focus on the fields of integrated circuits, basic electronics and complete machine systems, and cultivate and expand a number of emerging industries and future industries. It is necessary to plan the "15th Five-Year Plan" development plan for the electronic information manufacturing industry, accelerate the high-end, intelligent and green transformation of traditional industries, support the development of new products, new formats and new models, and strive to improve the industry governance system. It is necessary to strengthen coordination and linkage, coordinate the forces of all parties, form a joint work force, and strive to promote the systematic breakthrough of the electronic information manufacturing industry. It is necessary to make good use of domestic and international resources and markets, create a sustainable and safe development environment, and improve the resilience and security of industrial and supply chains.

[Science and Technology Innovation Board Company].

Autel Technology: It is expected to achieve manufacturing substitution in low-tariff areas within 1 month

Regarding the impact of U.S. tariffs and countermeasures, the relevant person in charge of Autel Technology replied to the reporter of "Science and Technology Innovation Board Daily" that the current U.S. reciprocal tariffs are a preliminary plan, and it is not ruled out that there will be changes in the follow-up process. Based on the current situation, the company will take the following countermeasures: first, based on the current reciprocal tariff policy, it has found manufacturing sites in some low-tariff countries or regions (such as Mexico, Turkey, Hungary, Singapore, etc.) in advance and carried out relevant personnel reserves, and it is expected that manufacturing substitution in low-tariff areas can be realized within one month; Second, some product lines (such as TPMS, charging piles, etc.) can be manufactured in the United States, and the company's North Carolina plant in the United States has been put into operation at the end of 2023, and a complete supply chain and manufacturing system have been established in the United States. "In addition to the U.S. market, the company has a complete marketing service system construction and layout in the European market and the vast emerging markets such as the Asia-Pacific, the Middle East and South America." As of press time, Autel Technology fell 12.15%, with a market value of 16.792 billion yuan.

Chengda Biological: Shaoguan Gaoteng's tender offer expired and the stock was suspended for one day

Chengda Biotechnology (688739.SH) announced that due to Shaoguan Gaoteng's offer to acquire the company's shares, the company's shares will be suspended for one trading day on April 7, 2025. The tender offer period is from March 5 to April 3, 2025, and the number of shares scheduled to be acquired in the tender offer is 184 million shares, accounting for 44.18% of the company's total share capital, and the tender offer price is 25.51 yuan per share. During the suspension period, the company will fulfill its information disclosure obligations in a timely manner in accordance with relevant regulations, and resume trading on the day of the announcement of the tender offer results.

Gaotse shares: The controlling shareholder Zhang Ji intends to inquire about the transfer of 4.99% of the shares

Gaoce Co., Ltd. (688556.SH) announced that the company's controlling shareholder Zhang Ji plans to transfer 27,308,000 shares, accounting for 4.99% of the company's total share capital, through inquiry transfer, and the reason for the transfer is his own capital needs. The transferor declares that the ownership of the shares held by the transferor is clear, there is no restriction or prohibition on transfer, and there is no violation of the relevant shareholding reduction regulations and commitments. The transferee of this inquiry transfer shall be an institutional investor with corresponding pricing power and risk tolerance. The lower price of this inquiry transfer shall not be less than 70% of the average trading price of Gaotei shares in the 20 trading days before the date of sending the subscription invitation (i.e., April 3, 2025).

Sany Renewable Energy: It is planned to invest a total of no more than US$1 billion to build two wind farm projects in Uzbekistan

Sany Renewable Energy (688349.SH) announced that the company intends to sign an investment agreement with the government of the Republic of Uzbekistan to set up two wholly-owned subsidiaries in Uzbekistan to invest in the construction of Kungrad Wind Farm 1 Project and Kungrad Wind Farm 2 Project respectively, with an investment amount of no more than 500 million US dollars respectively.

Debang Technology: It is planned to repurchase the company's shares for 40 million yuan to 80 million yuan

Debang Technology (688035.SH) announced that the company intends to repurchase part of the company's issued RMB ordinary shares (A shares) through centralized bidding transactions, with a total repurchase fund of not less than 40 million yuan (inclusive) and no more than 80 million yuan (inclusive). The repurchase price shall not be higher than 63.52 yuan / share (inclusive). The repurchase period shall be within 12 months from the date of approval of the repurchase plan by the board of directors.

Roborock: Net profit in 2024 will decrease by 3.64% year-on-year, and it is planned to distribute 10.7 to 4 for every 10 distributions

Roborock (688169.SH) announced that Roborock released its 2024 annual report, and the company achieved operating income of 11.945 billion yuan, a year-on-year increase of 38.03%; Net profit attributable to shareholders of the Company was RMB1.977 billion (consolidated statement), a decrease of 3.64% year-on-year. The company plans to distribute a cash dividend of 1.07 yuan (tax included) per share to all shareholders, with a total cash dividend of 198 million yuan (tax included). At the same time, the company intends to use the capital reserve to increase 4 shares for every 10 shares to all shareholders.

Huitai Medical: Deputy General Manager Han Yonggui plans to reduce his holdings of no more than 0.0309% of the company's shares

Huitai Medical (688617.SH) announced that Han Yonggui, deputy general manager of the company, plans to reduce his holdings through centralized bidding and block trading, with a total of no more than 30,000 shares, that is, no more than 0.0309% of the company's total share capital. The reduction period is three months after 15 trading days from the date of disclosure of the announcement. The price of the reduction will be determined based on the market price.

Zhongke Flying Measurement: The net profit loss in 2024 will be 11.5251 million yuan

Zhongke Feice (688361.SH) announced that the company's net profit attributable to shareholders of listed companies in 2024 will be -11.5251 million yuan.

[Venture capital vane].

Hanfang New Materials received tens of millions of yuan in Pre-A round financing

Recently, Hanfang New Material Technology (Guangzhou) Co., Ltd. completed tens of millions of yuan in Pre-A round of financing, and the investors in this round are Walden International, Xinyuan Zhenghe, and Qianhai HSBC. The funds from this round of financing will be used to increase R&D investment, further expand the market and upgrade the team. Founded in 2023 and headquartered in Guangzhou, Hanfang New Materials focuses on high-end semiconductor adhesives and builds a semiconductor material platform enterprise, including conductive or non-conductive adhesives, adhesive films, and high thermal conductivity sintering materials and other products, which are widely used in LED, IC packaging, consumer electronics, automotive electronics and other industries. According to the data of the Venture Capital Connect of the Financial Associated Press, taking April 2025 as the forecast base time, the financing forecast probability for the next two years is 63.18%.

Yuewei Medical completed about 100 million yuan in Series A+ financing

Recently, Beijing Yuewei Medical Technology Co., Ltd. completed about 100 million yuan in Series A+ financing, and the investor in this round is Shunxi Fund. Yuewei Medical is a research and development enterprise of implantable and interventional medical devices for cardiac surgery, which was initiated and established by a team of cardiac surgery experts with more than 20 years of clinical experience in Beijing Anzhen Hospital affiliated to Capital Medical University. The company focuses on the transformation and development of innovative products for the whole process of cardiac surgery medical devices and equipment solutions, and its series of products include coronary artery bypass grafting cardiac fixator, intraoperative ultrasound flow detector, left ventricular assist device, coronary anastomosis assist system and a series of domestic exclusive initiatives. This A+ round of financing will further promote the innovation and development of Yuewei Medical in the field of cardiac surgical medical devices. According to the data of the Venture Capital Connect of the Financial Associated Press, taking April 2025 as the forecast base time, the financing forecast probability for the next two years is 79.65%.

Non-stop Technology completed tens of millions of dollars in Series B financing

Recently, Shenzhen Non-stop Technology Co., Ltd. (hereinafter referred to as "Non-stop Technology") announced the completion of tens of millions of dollars in Series B financing, which was led by Wuyuan Capital and followed by Alphaist Partners. Non-stop Technology is an AI digital kitchen overall solution provider, through intelligent cooking robots and intelligent kitchen scheduling systems and other products, to ensure the consistency of dishes, help catering companies reduce labor costs, alleviate the problem of manpower shortage, improve operational efficiency and large-scale chain speed. According to the data of the Venture Capital Connect of the Financial Associated Press, taking April 2025 as the forecast base time, the financing forecast probability for the next two years is 85.59%.

Only Sanbio received about 100 million yuan in Pre-A round financing

Recently, Jiangsu Weisan Biotechnology Co., Ltd. completed a Pre-A round of financing of about 100 million yuan, and the investor in this round is JAFCO Asia. Founded in August 2021 and headquartered in Nanjing, Sonsan Biotech is a technology company focusing on the field of synthetic biology. The company integrates R&D, production and sales, and is committed to the innovation and application of synthetic biotechnology. This round of financing will be used to increase R&D investment, expand production scale and market expansion. Only Sanbio has received support from many parties in the angel round and Pre-A round of financing, and its synthetic biology technology has a leading edge in the industry. According to the data of the Venture Capital Connect of the Financial Associated Press, taking April 2025 as the forecast base time, the financing forecast probability for the next two years is 64.94%.